These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 26872862)

  • 1. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
    McKimm-Breschkin JL; Fry AM
    Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.
    Hurt AC; Hui DS; Hay A; Hayden FG
    Influenza Other Respir Viruses; 2015 Jan; 9(1):20-31. PubMed ID: 25399715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
    Ison MG; Hayden FG; Hay AJ; Gubareva LV; Govorkova EA; Takashita E; McKimm-Breschkin JL
    Antiviral Res; 2021 Oct; 194():105158. PubMed ID: 34363859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.
    Beigel JH; Nam HH; Adams PL; Krafft A; Ince WL; El-Kamary SS; Sims AC
    Antiviral Res; 2019 Jul; 167():45-67. PubMed ID: 30974127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
    Brooks MJ; Sasadeusz JJ; Tannock GA
    Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy of influenza.
    Englund JA
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):120-8. PubMed ID: 12122950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral treatment of influenza in humans].
    Nüesch R
    Ther Umsch; 2007 Nov; 64(11):635-41. PubMed ID: 18581908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals--current trends in fighting influenza.
    Król E; Rychłowska M; Szewczyk B
    Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.
    McKimm-Breschkin JL; Jiang S; Hui DS; Beigel JH; Govorkova EA; Lee N
    Antiviral Res; 2018 Jan; 149():118-142. PubMed ID: 29162476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy for respiratory viral infections in immunocompromised patients.
    Shahani L; Ariza-Heredia EJ; Chemaly RF
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):401-415. PubMed ID: 28067078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
    Hayden FG
    Antiviral Res; 1985; Suppl 1():229-39. PubMed ID: 2417551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and novel antiviral strategies for influenza infection.
    Yen HL
    Curr Opin Virol; 2016 Jun; 18():126-34. PubMed ID: 27344481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
    Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
    Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Treatments.
    Ison MG
    Clin Chest Med; 2017 Mar; 38(1):139-153. PubMed ID: 28159156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral resistance in influenza viruses--implications for management and pandemic response.
    Hayden FG
    N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.